MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-KL-07-0022126
Vanchinad Pharma Private Limited
Vanchinad Pharma Private Limited - pharma in Kottayam, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹25.1 Cr
▲ 22% YoY
Net profit · FY 2025
₹2.03 Lakh
Net margin 0.1%
EBITDA · FY 2025
₹29.6 Lakh
EBITDA margin 1.2%
Authorised capital
₹60 Lakh
Registered with MCA
Paid-up capital
₹39.69 Lakh
Issued & subscribed
Open charges
₹1.98 Cr
Secured borrowings
Company age
15 yrs
Est. 2011
Directors on board
7
As per MCA filings
About Vanchinad Pharma Private Limited
Data last updated:
Vanchinad Pharma Private Limited is a private limited company based in Kottayam, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 August 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U51397KL2011PTC029175. Its GSTIN is 32AADCV8437C1ZI (Kerala).
The company has an authorised share capital of ₹60 Lakh and a paid-up capital of ₹39.69 Lakh. It is led by directors including Jack Mathew and Manoj Kumar.
Its last annual general meeting (AGM) was held on 28 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at IX/564 Second Floor Parackal Building Shastri Road, Kottayam, Kerala, India – 686001.
As per the financials filed for FY 2025, the company reported a revenue of ₹25.1 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹2.03 Lakh (net margin 0.1%) and EBITDA of ₹29.6 Lakh (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 41% over three years and 19% over five years.
As per MCA filings, the company has open charges of ₹1.98 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
Vanchinad Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-KL-07-0022126). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51397KL2011PTC029175
Registration Number 029175
Incorporation Date 19 August 2011
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 28 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-KL-07-0022126
Recognitions & Rankings of Vanchinad Pharma
Contact details
Vanchinad Pharma Private Limited's registered office is in Kottayam, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressIX/564 Second Floor Parackal Building Shastri Road, Kottayam, Kerala, India – 686001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Vanchinad Pharma Private Limited, buy the company report.
Comprehensive company report
Vanchinad Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Vanchinad Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Vanchinad Pharma Private Limited, buy the company report.
Financials of Vanchinad Pharma Private Limited
FY 2025 filings availableVanchinad Pharma Private Limited reported revenue of ₹25.1 Cr (up 22% YoY) for FY 2025.
Revenue · FY 2025
₹25.1 Cr ▲ 22%
Net profit · FY 2025
₹2.03 Lakh margin 0.1%
EBITDA · FY 2025
₹29.6 Lakh margin 1.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 41%
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▼ 47%
3 years · compounded
▲ 74%
5 years · compounded
▲ 42%
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 22% growth in the latest year. EBITDA fell 47% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹29.6 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.03 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vanchinad Pharma Private Limited, buy the company report.
Board of directors of Vanchinad Pharma Private Limited
Vanchinad Pharma has 7 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jack Mathew | Director | 10 Jun 2022 | 4 Years 4 Months | Current |
| Manoj Kumar | Director | 13 Apr 2024 | 2 Years 6 Months | Current |
| Sebastian Varghese | Director | 04 Aug 2021 | 5 Years 3 Months | Current |
| Tomy Pampoorickal Mathew | Director | 04 Aug 2021 | 5 Years 3 Months | Current |
| Sony Jacob | Director | 04 Aug 2021 | 5 Years 3 Months | Current |
| Joji Abraham | Director | 04 Aug 2021 | 5 Years 3 Months | Current |
Showing 6 of 7 current directors. View all directors
Peer comparison
Vanchinad Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rainbow Life Sciences Private Limited | ₹25.18 Cr (FY 2025) | -12.0% | Navi Mumbai, Maharashtra, India | |||
| Vanchinad Pharma Private Limitedthis company | ₹25.1 Cr (FY 2025) | ₹2.03 Lakh | 0.1% | 22.0% | Kottayam, Kerala, India | |
| White Line Pharma Private Limited | ₹25.07 Cr (FY 2025) | 12.0% | Kalpetta, Kerala, India | |||
| Comship Medix and Infra Private Limited | ₹25.05 Cr (FY 2022) | 1092.0% | Patna, Bihar, India | |||
| SD Jain Pharmaceuticals Private Limited | ₹25 Cr (FY 2024) | 4.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Vanchinad Pharma Private Limited, buy the company report.
Auditor
Vanchinad Pharma Private Limited is audited by TOM AND JIM CHARTERED ACCOUNTANTS for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| TOM AND JIM CHARTERED ACCOUNTANTS | FY 2023 | 008243S |
Shareholding
The shareholding of Vanchinad Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vanchinad Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.98 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 May 2023 | 100729652 | State Bank of India | ₹1.98 Cr | Open |
To see the full charge records of Vanchinad Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Vanchinad Pharma Private Limited has 1 court case on record: 1 filed by Vanchinad Pharma. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Kottayam, Kerala | Criminal miscellaneous application | Filed by the company against an individual | Disposed |
To see the full case history of Vanchinad Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vanchinad Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vanchinad Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AADCV8437C1ZI | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vanchinad Pharma Private Limited, buy the company report.
Recent activity
Vanchinad Pharma Private Limited has 24 board changes on record since 2014: 7 appointments and 17 cessations. The latest: Manoj Kumar ceased to be Additional Director on 11 Jan 2025.
AGM
Vanchinad Pharma Private Limited last Annual general meeting of members was held on 28 Sep 2025 as per latest MCA records.
Filing
Vanchinad Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Ceased
Manoj Kumar ceased to be Additional Director.
Ceased
Varughese Kureekattu Joseph ceased to be Additional Director.
Ceased
Joji Abraham ceased to be Director.
Ceased
Sony Jacob ceased to be Director.
Appointed
Manoj Kumar was appointed as Director.
Appointed
Varughese Kureekattu Joseph was appointed as Director.
Charges
A charge with State Bank Of India of Rs. 198.00 Lakh registered on 31 May 2023 with Charge ID 100729652 was modified on 08 Feb 2024.
Charges
A charge with State Bank Of India amounted to Rs. 198.00 Lakh with Charge ID 100729652 was registered on 31 May 2023.
Ceased
Binu John ceased to be Additional Director.
Ceased
Jack Mathew ceased to be Additional Director.
17 earlier events are in the company report.
Frequently asked questions
Vanchinad Pharma is an active private limited company based in Kottayam, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 August 2011 (15+ years old) and is registered under CIN U51397KL2011PTC029175.
Vanchinad Pharma has 7 current directors:
- Jack Mathew - Director
- Manoj Kumar - Director
- Sebastian Varghese - Director
- Tomy Pampoorickal Mathew - Director
- Sony Jacob - Director
- Joji Abraham - Director
- Varughese Kureekattu Joseph - Director
The latest financial statements of Vanchinad Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Vanchinad Pharma is 32AADCV8437C1ZI, registered in Kerala.
The CIN (Corporate Identification Number) of Vanchinad Pharma is U51397KL2011PTC029175. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vanchinad Pharma has 1 court case on record: 1 filed by the company.
Vanchinad Pharma was incorporated on 19 August 2011, making it 15+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Vanchinad Pharma by revenue are Rainbow Life Sciences Private Limited, White Line Pharma Private Limited, Comship Medix and Infra Private Limited, SD Jain Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Manoj Kumar ceased to be Additional Director on 11 Jan 2025. Varughese Kureekattu Joseph ceased to be Additional Director on 11 Jan 2025. Joji Abraham ceased to be Director on 30 Dec 2024. Vanchinad Pharma has 24 board changes on record in total.
Yes, Vanchinad Pharma is registered as an MSME under Udyam registration (number: UDYAM-KL-07-0022126).
The registered office of Vanchinad Pharma is at IX564 Second Floor Parackal Building Shastri Road, Kottayam, Kerala, India – 686001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages